Potential Risks of Ketamine Therapy I asked Meisner about the risks of ketamine therapy, including whether ketamine can be addictive
A massive market for the breakthrough drugs First developed to manage type 2 diabetes, GLP-1 medications regulate blood-sugar levels, which can help people curb cravings and feel fuller after eating
Even the review paper summarizing this study noted the results are not overly informative and reliable due to the lack of objective measures
losing it makes maintaining weight loss harder Higher risk of weight regain: A lower metabolic rate makes stopping or reducing medication much riskier Reduced functional strength: Weakness, limited mobility, and increased fall risk are all linked to muscle loss Impaired blood sugar regulation: Muscle plays a direct role in how the body processes glucose after meals How to Preserve Muscle Mass on GLP-1 Medications Research shows that muscle loss during GLP-1 therapy is not inevitable
This listing is not intended to provide clinical, injection, compounding, or consumer-use instructions
Officials at AstraZeneca report that their new medication, elecoglipron, helped people with type 2 diabetes reduce blood glucose levels and lose 10.5% of their body weight at 26 weeks
